153 related articles for article (PubMed ID: 35445343)
1. The Implications of Treatment Delays in Adjuvant Therapy for Resected Cholangiocarcinoma Patients.
Parsons M; Lloyd S; Johnson S; Scaife C; Soares H; Kim R; Kim R; Garrido-Laguna I; Tao R
J Gastrointest Cancer; 2023 Jun; 54(2):492-500. PubMed ID: 35445343
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis.
Yadav S; Xie H; Bin-Riaz I; Sharma P; Durani U; Goyal G; Borah B; Borad MJ; Smoot RL; Roberts LR; Go RS; McWilliams RR; Mahipal A
Eur J Surg Oncol; 2019 Aug; 45(8):1432-1438. PubMed ID: 30914290
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of adjuvant radiation therapy after chemotherapy in resected extrahepatic cholangiocarcinoma: A National Cancer Database analysis.
Shridhar R; Blinn P; Huston J; Meredith KL
Cancer; 2023 Mar; 129(6):890-900. PubMed ID: 36544387
[TBL] [Abstract][Full Text] [Related]
4. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
Tran Cao HS; Zhang Q; Sada YH; Chai C; Curley SA; Massarweh NN
Cancer; 2018 Jan; 124(1):74-83. PubMed ID: 28841223
[TBL] [Abstract][Full Text] [Related]
5. Locoregional recurrence after curative intent resection for intrahepatic cholangiocarcinoma: implications for adjuvant radiotherapy.
Song S; Kim K; Chie EK; Kim S; Park HJ; Yi NJ; Suh KS; Ha SW
Clin Transl Oncol; 2015 Oct; 17(10):825-9. PubMed ID: 26041722
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of adjuvant chemotherapy in T1N0M0 intrahepatic cholangiocarcinoma after radical resection.
Li XH; Zhao CY; Zhou EL; Lin XJ
BMC Cancer; 2022 Nov; 22(1):1159. PubMed ID: 36357848
[TBL] [Abstract][Full Text] [Related]
7. Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis.
Vern-Gross TZ; Shivnani AT; Chen K; Lee CM; Tward JD; MacDonald OK; Crane CH; Talamonti MS; Munoz LL; Small W
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):189-98. PubMed ID: 20971573
[TBL] [Abstract][Full Text] [Related]
8. Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis.
Ecker BL; Vining CC; Roses RE; Maggino L; Lee MK; Drebin JA; Fraker DL; Vollmer CM; Datta J
Ann Surg Oncol; 2017 Dec; 24(13):3926-3933. PubMed ID: 28952140
[TBL] [Abstract][Full Text] [Related]
9. R0 but not R1/R2 resection is associated with better survival than palliative photodynamic therapy in biliary tract cancer.
Matull WR; Dhar DK; Ayaru L; Sandanayake NS; Chapman MH; Dias A; Bridgewater J; Webster GJ; Bong JJ; Davidson BR; Pereira SP
Liver Int; 2011 Jan; 31(1):99-107. PubMed ID: 20846273
[TBL] [Abstract][Full Text] [Related]
10. Survival benefit with adjuvant radiotherapy after resection of distal cholangiocarcinoma: A propensity-matched National Cancer Database analysis.
Kamarajah SK; Bednar F; Cho CS; Nathan H
Cancer; 2021 Apr; 127(8):1266-1274. PubMed ID: 33320344
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Post-operative Adjuvant Chemotherapy Versus Adjuvant Chemoradiation Therapy Outcomes in Non-metastatic Cholangiocarcinoma: an NCDB Review.
Rodriguez RR; Abel S; Mamadgi J; Renz PB; Wegner RE; Raj MS
J Gastrointest Cancer; 2022 Sep; 53(3):700-708. PubMed ID: 34486086
[TBL] [Abstract][Full Text] [Related]
12. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.
de Jong MC; Marques H; Clary BM; Bauer TW; Marsh JW; Ribero D; Majno P; Hatzaras I; Walters DM; Barbas AS; Mega R; Schulick RD; Choti MA; Geller DA; Barroso E; Mentha G; Capussotti L; Pawlik TM
Cancer; 2012 Oct; 118(19):4737-47. PubMed ID: 22415526
[TBL] [Abstract][Full Text] [Related]
13. Radiation therapy is associated with improved survival in the adjuvant and definitive treatment of intrahepatic cholangiocarcinoma.
Shinohara ET; Mitra N; Guo M; Metz JM
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1495-501. PubMed ID: 18472359
[TBL] [Abstract][Full Text] [Related]
14. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
[TBL] [Abstract][Full Text] [Related]
15. [Impact of adjuvant chemotherapy on prognosis in intrahepatic cholangiocarcinoma patients underwent radical resection].
Su JB; Zhang JW; Chen C; Qiu YH; Wu H; Song TQ; He Y; Mao XH; Zhai WL; Cheng ZJ; Li JD; Si SB; Cai ZQ; Geng ZM; Tang Z
Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):356-362. PubMed ID: 35272427
[No Abstract] [Full Text] [Related]
16. Lymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma: a multi-institution analysis.
Fisher SB; Patel SH; Kooby DA; Weber S; Bloomston M; Cho C; Hatzaras I; Schmidt C; Winslow E; Staley CA; Maithel SK
HPB (Oxford); 2012 Aug; 14(8):514-22. PubMed ID: 22762399
[TBL] [Abstract][Full Text] [Related]
17. Postoperative adjuvant therapy following radical resection for intrahepatic cholangiocarcinoma: A multicenter retrospective study.
Wang L; Deng M; Ke Q; Lou J; Zheng S; Bi X; Wang J; Guo W; Li F; Wang J; Zheng Y; Li J; Cheng S; Zhou W; Zeng Y
Cancer Med; 2020 Apr; 9(8):2674-2685. PubMed ID: 32072774
[TBL] [Abstract][Full Text] [Related]
18. Association of Liver-Directed Local Therapy With Overall Survival in Adults With Metastatic Intrahepatic Cholangiocarcinoma.
Sebastian NT; Tan Y; Miller ED; Williams TM; Noonan AM; Hays JL; Abdel-Misih S; Diaz DA
JAMA Netw Open; 2019 Sep; 2(9):e1911154. PubMed ID: 31517963
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant Chemotherapy for Intrahepatic, Perihilar, and Distal Cholangiocarcinoma: a National Population-Based Comparative Cohort Study.
Parente A; Kamarajah SK; Baia M; Tirotta F; Manzia TM; Hilal MA; Pawlik TM; White SA; Dahdaleh FS
J Gastrointest Surg; 2023 Apr; 27(4):741-749. PubMed ID: 36749556
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant therapy is associated with improved survival after curative resection for hilar cholangiocarcinoma: A multi-institution analysis from the U.S. extrahepatic biliary malignancy consortium.
Krasnick BA; Jin LX; Davidson JT; Sanford DE; Ethun CG; Pawlik TM; Poultsides GA; Tran T; Idrees K; Hawkins WG; Chapman WC; Doyle MBM; Weber SM; Strasberg SM; Salem A; Martin RCG; Isom CA; Scoggins C; Schmidt CR; Shen P; Beal E; Hatzaras I; Shenoy R; Maithel SK; Fields RC
J Surg Oncol; 2018 Mar; 117(3):363-371. PubMed ID: 29284072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
